Williams, L. M., Fu, Z., Dulloor, P., Savage, W. J., Barron-Casella, E., Strouse, J. J., … Casella, J. F. (2009). Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease. In BLOOD (Vol. 114, pp. 1012–1013). New Orleans, LA: AMER SOC HEMATOLOGY.

Williams, Lisa M., Zongming Fu, Pratima Dulloor, William J. Savage, Emily Barron-Casella, John J. Strouse, Michael R. DeBaun, Jennifer Van Eyk, Allen Everett, and James F. Casella. “Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.” In BLOOD, 114:1012–13. AMER SOC HEMATOLOGY, 2009.

Williams LM, Fu Z, Dulloor P, Savage WJ, Barron-Casella E, Strouse JJ, et al. Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease. In: BLOOD. AMER SOC HEMATOLOGY; 2009. p. 1012–3.

Williams, Lisa M., et al. “Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease.” BLOOD, vol. 114, no. 22, AMER SOC HEMATOLOGY, 2009, pp. 1012–13.

Williams LM, Fu Z, Dulloor P, Savage WJ, Barron-Casella E, Strouse JJ, DeBaun MR, Van Eyk J, Everett A, Casella JF. Proteomic-Based Approach for Biomarker Discovery to Predict Silent Cerebral Infarct in Patients with Sickle Cell Disease. BLOOD. AMER SOC HEMATOLOGY; 2009. p. 1012–1013.